STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
AKRO AKERO THERAPEUTICS INCORPORATED StockScouter® Report
2
StockScouter® Score
AKERO THERAPEUTICS INCORPORATED, a small cap company in the healthcare sector, is expected to underperform the market over the next six months with slightly higher than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- Shares are under accumulation by financial institutions. Marginally positive for a small company like AKRO
Concerns
- The most recent quarterly earnings report was significantly lower than analysts’ consensus forecast. Negative
- The multi-period measure of relative price change and consistency is well below average. Negative
- Moving average analysis for AKRO suggests weak price movement over the medium term. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that small cap stocks will be out of favor, stocks will be , and healthcare stocks will be out of favor.
Expected Risk/Return
Core Model Grades
D
D
N/A
F